Skip to content

Damage and Renal Clearance of Glycocalyx in Cardiac Surgery

Damage and Renal Clearance of Glycocalyx in Cardiac Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04332952
Acronym
GlycoCarSur
Enrollment
21
Registered
2020-04-03
Start date
2017-08-01
Completion date
2017-12-31
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardio-Renal Syndrome, Glycocalyx

Keywords

Renal clearance, Glycocalyx, Cardiac surgery

Brief summary

The glycocalyx is a component of the vascular endothelium that currently plays a relevant role in the modified Starling theory. The manipulation of the heart during cardiac surgery stimulates the release of the natriuretic atrial peptide, which causes endothelial wear in patients undergoing extracorporeal circulation. Dilation of the atrium produces natriuretic atrial peptide, which reduces plasma volume by increasing renal excretion and vascular permeability. The atrial peptide degrades the surface of the coronary endothelium, causing loss of the side cam protein nucleus. This study investigates the relationship between clamping time in cardiac surgery and the clearance of endothelial inflammation markers.

Interventions

None listed

Sponsors

Instituto Nacional de Cardiologia Ignacio Chavez
CollaboratorOTHER
Miguel Ayala León
Lead SponsorNETWORK

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Over 18 years of age * Patients who underwent cardiac surgery for a single valve change or replacement

Exclusion criteria

* Stage 3 renal failure patients * Patients with a previous diagnosis of hematological malignancy * Patients undergoing pulmonary valve change surgery. * Patients undergoing Bentall and Bono surgery. * Patients Undergoing Coronary Artery Bypass Surgery

Design outcomes

Primary

MeasureTime frameDescription
Sydecan -1 levels in urine before surgery30 minutesQuantity of Sydecan -1 in urine before surgery
Sydecan -1 levels in urine after surgery30 minutesQuantity of Sydecan -1 in urine after surgery
Extracorporeal circulation time2 hoursDuration of Extracorporeal Circulation in minutes
Aortic clamping time2 hoursDuration of aortic clamping time in minutes
Hyaluronic acid levels in blood before surgery30 minutesQuantity of hyaluronic acid in blood before surgery
Hyaluronic acid levels in blood after surgery30 minutesQuantity of hyaluronic acid in blood after surgery
Hyaluronic acid levels in urine before surgery30 minutesQuantity of hyaluronic acid in urine before surgery
Hyaluronic acid levels in urine after surgery30 minutesQuantity of hyaluronic acid in urine before surgery
Sydecan -1 levels in blood before surgery30 minutesQuantity of Sydecan -1 in blood before surgery
Sydecan -1 levels in blood after surgery30 minutesQuantity of Sydecan -1 in blood after surgery

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026